Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1981 Oct;34(1):20–25. doi: 10.1128/iai.34.1.20-25.1981

Serum antibody and opsonic responses after immunization with pneumococcal vaccine in kidney transplant recipients and controls.

R Bortolussi, T J Marrie, J Cunningham, G Schiffman
PMCID: PMC350814  PMID: 7028628

Abstract

We immunized 31 renal transplant patients and 6 control subjects with a pneumococcal vaccine containing 14 capsular polysaccharides. Antibody levels to Streptococcus pneumoniae types 3 and 6A were measured by a radioimmunoassay, and opsonic activity to S. pneumoniae types 3 and 6B was determined by using a luminol-enhanced chemiluminescence phagocytic assay on serum samples obtained before and 1 month after immunization. There was a 10.2-fold and a 2.9-fold increase in antibody to S. pneumoniae type 3 (P less than 0.005) and type 6A (P less than 0.01), respectively, but only a 1.3-fold (P greater than 0.05) and 1.1-fold (P greater than 0.05) increase in opsonic activity. For S. pneumoniae type 3, changes in opsonic activity correlated well with antibody concentration (P less than 0.05). However, for S. pneumoniae type 6, these two tests correlated poorly (P greater than 0.05). This poor correlation suggests that concentrations of antibody to type 6A polysaccharide which are achieved after immunization may not be opsonically active in vitro against S. pneumoniae type 6B.

Full text

PDF
20

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andersen B. R., Amirault H. J. Important variables in granulocyte chemiluminescence. Proc Soc Exp Biol Med. 1979 Oct;162(1):139–145. doi: 10.3181/00379727-162-40633. [DOI] [PubMed] [Google Scholar]
  2. Austrian R. Pneumococcal infection and pneumococcal vaccine. N Engl J Med. 1977 Oct 27;297(17):938–939. doi: 10.1056/NEJM197710272971712. [DOI] [PubMed] [Google Scholar]
  3. Broome C. V., Facklam R. R., Fraser D. W. Pneumococcal disease after pneumococcal vaccination: an alternative method to estimate the efficacy of pneumococcal vaccine. N Engl J Med. 1980 Sep 4;303(10):549–552. doi: 10.1056/NEJM198009043031003. [DOI] [PubMed] [Google Scholar]
  4. Cheson B. D., Christensen R. L., Sperling R., Kohler B. E., Babior B. M. The origin of the chemiluminescence of phagocytosing granulocytes. J Clin Invest. 1976 Oct;58(4):789–796. doi: 10.1172/JCI108530. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Giebink G. S., Foker J. E., Kim Y., Schiffman G. Serum antibody and opsonic responses to vaccination with pneumococcal capsular polysaccharide in normal and splenectomized children. J Infect Dis. 1980 Mar;141(3):404–412. doi: 10.1093/infdis/141.3.404. [DOI] [PubMed] [Google Scholar]
  6. Giebink G. S., Verhoef J., Peterson P. K., Quie P. G. Opsonic requirements for phagocytosis of Streptococcus pneumoniae types VI, XVIII, XXIII, and XXV. Infect Immun. 1977 Nov;18(2):291–297. doi: 10.1128/iai.18.2.291-297.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Guckian J. C., Christensen G. D., Fine D. P. The role of opsonins in recovery from experimental pneumococcal pneumonia. J Infect Dis. 1980 Aug;142(2):175–190. doi: 10.1093/infdis/142.2.175. [DOI] [PubMed] [Google Scholar]
  8. HIRSCH J. G., STRAUSS B. STUDIES ON HEAT-LABILE OPSONIN IN RABBIT SERUM. J Immunol. 1964 Jan;92:145–154. [PubMed] [Google Scholar]
  9. Levine P. H., Merrill D. A., Kohler P. F., Claman H. N. Changes in serum immunoglobulin and complement levels following renal homotransplantation. Transplantation. 1970 Aug;10(2):141–154. doi: 10.1097/00007890-197008000-00001. [DOI] [PubMed] [Google Scholar]
  10. Linnemann C. C., Jr, First M. R. Risk of pneumococcal infections in renal transplant patients. JAMA. 1979 Jun 15;241(24):2619–2621. [PubMed] [Google Scholar]
  11. Marrie T. J., Schiffman G., Bortolussi R., Field C., Whalen A. Humoral immune response of kidney transplant recipients to pneumococcal vaccine. Proc Soc Exp Biol Med. 1981 May;167(1):62–69. doi: 10.3181/00379727-167-41126. [DOI] [PubMed] [Google Scholar]
  12. Matthay K. K., Mentzer W. C., Wara D. W., Preisler H. K., Lameris N. B., Ammann A. J. Evaluation of the opsonic requirements for phagocytosis of Streptococcus pneumoniae serotypes VII, XIV, and XIX by chemiluminescence assay. Infect Immun. 1981 Jan;31(1):228–235. doi: 10.1128/iai.31.1.228-235.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Mäkelä P. H., Sibakov M., Herva E., Henrichsen J., Luotonen J., Timonen M., Leinonen M., Koskela M., Pukander J., Pöntynen S. Pneumococcal vaccine and otitis media. Lancet. 1980 Sep 13;2(8194):547–551. doi: 10.1016/s0140-6736(80)91989-3. [DOI] [PubMed] [Google Scholar]
  14. Robbins J. B., Lee C. J., Rastogi S. C., Schiffman G., Henrichsen J. Comparative immunogenicity of group 6 pneumococcal type 6A(6) and type 6B(26) capsular polysaccharides. Infect Immun. 1979 Dec;26(3):1116–1122. doi: 10.1128/iai.26.3.1116-1122.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Schiffman G., Douglas R. M., Bonner M. J., Robbins M., Austrian R. A radioimmunoassay for immunologic phenomena in pneumococcal disease and for the antibody response to pneumococcal vaccines. I. Method for the radioimmunoassay of anticapsular antibodies and comparison with other techniques. J Immunol Methods. 1980;33(2):133–144. doi: 10.1016/s0022-1759(80)80004-4. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES